According to WiseGuy Reports, the Sulfanilamide Market generated USD 0.73 billion in 2024 following a valuation of USD 0.69 billion in 2023 and is projected to reach USD 1.12 billion by 2032, expanding at a CAGR of 5.48% during the forecast period. Increasing pharmaceutical demand, rising incidence of infectious diseases, advances in drug delivery technologies, expanding healthcare...